793 related articles for article (PubMed ID: 9129864)
1. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
Parnetti L; Senin U; Mecocci P
Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
[TBL] [Abstract][Full Text] [Related]
2. Association between chronic stress and Alzheimer's disease: Therapeutic effects of Saffron.
Saeedi M; Rashidy-Pour A
Biomed Pharmacother; 2021 Jan; 133():110995. PubMed ID: 33232931
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
Peskind ER
J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
[TBL] [Abstract][Full Text] [Related]
4. A review on cholinesterase inhibitors for Alzheimer's disease.
Anand P; Singh B
Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
[TBL] [Abstract][Full Text] [Related]
5. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
7. Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs.
Grundman M; Corey-Bloom J; Thal LJ
J Neural Transm Suppl; 1998; 53():255-75. PubMed ID: 9700663
[TBL] [Abstract][Full Text] [Related]
8. Toward an early diagnosis and treatment of Alzheimer's disease.
Nordberg A
Int Psychogeriatr; 2003 Sep; 15(3):223-37. PubMed ID: 14756159
[TBL] [Abstract][Full Text] [Related]
9. Non-cholinergic strategies for treating and preventing Alzheimer's disease.
Doraiswamy PM
CNS Drugs; 2002; 16(12):811-24. PubMed ID: 12421115
[TBL] [Abstract][Full Text] [Related]
10. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.
Hampel H; Mesulam MM; Cuello AC; Farlow MR; Giacobini E; Grossberg GT; Khachaturian AS; Vergallo A; Cavedo E; Snyder PJ; Khachaturian ZS
Brain; 2018 Jul; 141(7):1917-1933. PubMed ID: 29850777
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of Alpinia galanga (L.) fractions on Aβ(25-35) induced amnesia in mice.
Hanish Singh JC; Alagarsamy V; Diwan PV; Sathesh Kumar S; Nisha JC; Narsimha Reddy Y
J Ethnopharmacol; 2011 Oct; 138(1):85-91. PubMed ID: 21911048
[TBL] [Abstract][Full Text] [Related]
12. The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease.
Pimentel LS; Allard S; Do Carmo S; Weinreb O; Danik M; Hanzel CE; Youdim MB; Cuello AC
J Alzheimers Dis; 2015; 47(2):373-83. PubMed ID: 26401560
[TBL] [Abstract][Full Text] [Related]
13. Is anti-cholinesterase therapy of Alzheimer's disease delaying progression?
Giacobini E
Aging (Milano); 2001 Jun; 13(3):247-54. PubMed ID: 11442306
[TBL] [Abstract][Full Text] [Related]
14. [Alzheimer's disease: from brain lesions to new drugs].
Forette F; Hauw JJ
Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
[TBL] [Abstract][Full Text] [Related]
15. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
[TBL] [Abstract][Full Text] [Related]
16. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach.
Davidson M; Stern RG
Psychiatr Clin North Am; 1991 Jun; 14(2):461-82. PubMed ID: 2062728
[TBL] [Abstract][Full Text] [Related]
17. [The role of the basal forebrain cholinergic dysfunction in pathogenesis of declarative memory disorder in Alzheimer's disease].
Mukhin VN
Ross Fiziol Zh Im I M Sechenova; 2013 Jun; 99(6):674-81. PubMed ID: 24459876
[TBL] [Abstract][Full Text] [Related]
18. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.
Modrego PJ; Pina MA; Fayed N; Díaz M
CNS Drugs; 2006; 20(10):867-77. PubMed ID: 16999455
[TBL] [Abstract][Full Text] [Related]
19. Tramiprosate.
Wright TM
Drugs Today (Barc); 2006 May; 42(5):291-8. PubMed ID: 16801992
[TBL] [Abstract][Full Text] [Related]
20. Role of natural products for the treatment of Alzheimer's disease.
Noori T; Dehpour AR; Sureda A; Sobarzo-Sanchez E; Shirooie S
Eur J Pharmacol; 2021 May; 898():173974. PubMed ID: 33652057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
